Archives of Cardiovascular Diseases (ARCH CARDIOVASC DIS)

Publisher: Elsevier Masson

Current impact factor: 1.84

Impact Factor Rankings

2016 Impact Factor Available summer 2017
2014 / 2015 Impact Factor 1.84
2013 Impact Factor 1.662
2012 Impact Factor 1.662
2011 Impact Factor 1.513
2010 Impact Factor 1.207
2009 Impact Factor 0.663
2008 Impact Factor 0

Impact factor over time

Impact factor

Additional details

5-year impact 1.83
Cited half-life 3.60
Immediacy index 0.45
Eigenfactor 0.00
Article influence 0.63
ISSN 1875-2136
OCLC 229941797
Material type Periodical
Document type Journal / Magazine / Newspaper

Publisher details

Elsevier Masson

  • Pre-print
    • Author can archive a pre-print version
  • Post-print
    • Author can archive a post-print version
  • Conditions
    • Authors pre-print on any website, including arXiv and RePEC
    • Author's post-print on author's personal website immediately
    • Author's post-print on open access repository after an embargo period of between 12 months and 48 months
    • Permitted deposit due to Funding Body, Institutional and Governmental policy or mandate, may be required to comply with embargo periods of 12 months to 48 months
    • Author's post-print may be used to update arXiv and RepEC
    • Publisher's version/PDF cannot be used
    • Must link to publisher version with DOI
    • Author's post-print must be released with a Creative Commons Attribution Non-Commercial No Derivatives License
    • Publisher last reviewed on 01/05/2015
    • 'Elsevier Masson' is an imprint of 'Elsevier'
  • Classification

Publications in this journal

  • [Show abstract] [Hide abstract]
    ABSTRACT: Atrial fibrillation (AF) is the most common rhythm disturbance. Among the major thromboembolic complications associated with AF, strokes are foremost, with a 4.4% yearly incidence in the absence of preventive treatment. Therefore, the prevention of these embolic accidents is a priority. While proof of the efficacy of oral anticoagulants (OACs) for this indication is long-standing and convincing, they are associated with haemorrhagic complications. Consequently, their prescription is based on an estimate of the risk (haemorrhagic complications)/benefit (thromboembolic prevention) ratio. In a patient subset at high thromboembolic and haemorrhagic risk, whether to prescribe or abstain from prescribing an OAC is a challenging decision, and an alternative means of thromboembolic prevention is desirable. Percutaneous occlusion of the left atrial appendage (LAA) is an alternative, interventional, nonpharmacological treatment that has been used widely in Europe and for a few years in France, with encouraging results. However, it remains an invasive procedure with a low level of proof in comparison with OACs. Moreover, the indications, the procedural environment and pre-per-post procedural patient management are major questions about this technique, with consequences on its efficacy and risk/benefit ratio. This document, composed by consensus among experts in the field, is an in-depth review of this new therapy.
    No preview · Article · Aug 2015 · Archives of Cardiovascular Diseases
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background. - Fenfluramine and its derivatives have been associated with significant risk of developing valvular heart disease but its exact prevalence and severity are still debated. Aim. - To evaluate the clinical and echocardiographic characteristics of patients hospitalized in a cardiology centre and who had past exposure to these drugs. Methods. - Between July 2011 and February 2012, patients admitted to the hospitalization and intensive care units at the University Centre of Montpellier, France were questioned about past exposure to fenfluramine or its derivatives. In patients who reported exposure, a questionnaire assessing prescribing patterns and medical history was proposed and echocardiography per-formed. All of the usual echocardiographic variables were analysed. We applied criteria from a French multicentre registry for diagnosis of drug-induced valvulopathy: leaflets and subvalvu-lar apparatus thickening and retraction, leaflets loss of coaptation, no calcification, and no stenosis.
    No preview · Article · Mar 2015 · Archives of Cardiovascular Diseases
  • [Show abstract] [Hide abstract]
    ABSTRACT: Ventricular septal defect (VSD) after acute myocardial infarction is a catastrophic event. We describe our multicentre experience of a defect closure strategy that combined surgery and transcatheter closure. Data were obtained by retrospective chart review. Twenty patients (mean age, 67years) from three centres were studied. Median time from myocardial infarction to VSD was 6 (range, 3-9) days. Acute cardiogenic shock occurred in 12 (60%) patients. Median defect diameter by echocardiography was 18 (range, 12-28) mm. Median time to first surgical or percutaneous closure was 18 (range, 4-96) days. Twenty-seven procedures were performed in the 20 patients. Surgical closure was undertaken in 14 patients and contraindicated in eight, six of whom underwent percutaneous closure; the other two, after reconsideration, proceeded to surgical closure. No procedural complications occurred with percutaneous closure. Percutaneous closure patients were older than surgical patients (75 vs. 64years; P=0.01) and had a higher mean logistic EuroSCORE (87% vs. 67%; P=0.02). Rates of residual shunt and mortality did not differ between surgical and percutaneous patients (P=0.12 and 0.3, respectively). Those who underwent early VSD closure (<21days after myocardial infarction) had higher rates of residual shunt (P=0.09) and mortality (P=0.01), irrespective of closure strategy. The mortality rate was also higher after early percutaneous closure (P=0.001), but not after early surgery. Finally, predicted mortality (logistic EuroSCORE) was higher than hospital mortality (≤30days) in our patient population (75% vs. 30%; P=0.01). Vigorous pursuit of closure of post-myocardial infarction VSD with a sequential surgical and/or percutaneous approach is recommended for improved outcomes. Copyright © 2015. Published by Elsevier Masson SAS.
    No preview · Article · Mar 2015 · Archives of Cardiovascular Diseases
  • [Show abstract] [Hide abstract]
    ABSTRACT: The latest recommendations of the European Society of Cardiology (ESC) have just been presented at the ESC Congress in Barcelona [1]; they updated existing literature on `sarcomeric' hypertrophic cardiomyopathy (HCM) from the ESC in 2003 [2], the Societe Francaise de Cardiologie/Haute Autorite de Sante (SEC/HAS) in 2011 [3], the American College of Cardiology/American Heart Association (ACC/AHA) in 2011 [4] and the American Society of Echocardiography (ASE) in 2011 [5]. The recommendations incorporate classical elements and innovate on some important points.
    No preview · Article · Feb 2015 · Archives of Cardiovascular Diseases
  • [Show abstract] [Hide abstract]
    ABSTRACT: The ideal duration of dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) is under debate. Lesion length is a well-recognized predictor of PCI complexity and long-term outcome. To evaluate the determinants and impact on outcome of long-term DAPT in a retrospective cohort of patients treated for a long coronary lesion. Patients (n=460) who underwent PCI for a long lesion (>30mm) were divided into two groups according to antiplatelet regimen at 1year: patients who stopped DAPT before 1year (single antiplatelet therapy group; n=168) and patients who continued DAPT for longer than 1year (n=292). Mean lesion length was 35.7±7.1mm. The proportion of patients who continued DAPT after 1year was 63.5%. The main determinants of long-term DAPT were initial presentation as myocardial infarction and implantation of a drug-eluting stent. Median follow-up was 37.4 (23-51) months after the 1-year period following the index PCI. Long-term DAPT was highly associated with a lower risk of all-cause and cardiovascular mortality by multivariable analysis and after adjustment for other predictors: hazard ratios 0.11 (95% confidence interval 0.03-0.32) and 0.15 (95% confidence interval 0.04-0.62), respectively. No increase in major bleeding was noted. In a contemporary practice, nearly two-thirds of patients who undergo PCI for a long lesion are treated with DAPT for several years. Our results suggest that long-term DAPT is beneficial in this subset of patients identified as being at high risk. Copyright © 2015 Elsevier Masson SAS. All rights reserved.
    No preview · Article · Feb 2015 · Archives of Cardiovascular Diseases
  • [Show abstract] [Hide abstract]
    ABSTRACT: Left ventricular diastolic dysfunction (LVDD) is common in sickle cell anaemia (SCA). Left atrial (LA) size is widely used as an index of LVDD; however, LA enlargement in SCA might also be due to chronic volume overload. To investigate whether LA size can be used to diagnose LVDD in SCA. One hundred and twenty-seven adults with stable SCA underwent echocardiographic assessment. LA volume was measured by the area-length method and indexed to body surface area (LAVi). Left ventricular (LV) filling pressures were assessed using the ratio of early peak diastolic velocities of mitral inflow and septal annular mitral plane (E/e'). Using mitral inflow profile and E/e', LV diastolic function was classified as normal or abnormal. LAVi>28mL/m(2) was used as the threshold to define LA enlargement. The mean age was 28.6±8.5years; there were 83 women. Mean LAVi was 48.3±11.1mL/m(2) and 124 (98%) patients had LA dilatation. In multivariable analysis, age, haemoglobin concentration and LV end-diastolic volume index were independent determinants of LAVi (R(2)=0.51; P<0.0001). E/e' was not linked to LAVi (P=0.43). Twenty patients had LVDD; when compared with patients without LVDD, they had a similar LAVi (52.2±14.7 and 47.5±10.2mL/m(2), respectively; P=0.29). Receiver operating characteristics curve analysis showed that LAVi could not be used to diagnose LVDD (area under curve=0.58; P=0.36). LA enlargement is common in SCA but appears not to be linked to LVDD. LAVi in this population is related to age, haemoglobin concentration and LV morphology. Copyright © 2014 Elsevier Masson SAS. All rights reserved.
    No preview · Article · Feb 2015 · Archives of Cardiovascular Diseases
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background. - Radiofrequency ablation (RFA) of paroxysmal atrial fibrillation (PAF) has focused on pulmonary vein isolation (PVI). However, despite initial positive results, significant recurr-ences have occurred, partly because of pulmonary vein (PV) reconnection or non-PV ectopic foci, including the superior vena cava (SVC). Objectives. - This prospective, randomized study sought to investigate the efficacy of addi-tional SVCI combined with PVI in symptomatic PAF patients referred for ablation. Methods. - From November 2011 to May 2013, RFA was performed remotely using a CARTO 3 System in patients randomized to undergo PVI for symptomatic drug-refractory PAF, with (PVI + SVCI group) or without (PVI alone group) SVCI. PVI and SVCI were confirmed by spiral catheter recording during ablation. Procedural data, complications and freedom from atrial tachycardia (AT) and atrial fibrillation (AF) were assessed.
    No preview · Article · Feb 2015 · Archives of Cardiovascular Diseases
  • [Show abstract] [Hide abstract]
    ABSTRACT: The early recognition of acute coronary syndromes is a priority in health care systems, to reduce revascularization delays. In France, patients are encouraged to call emergency numbers (15, 112), which are routed to a Medical Dispatch Centre where physicians conduct an interview and decide on the appropriate response. However, the effectiveness of this system has not yet been assessed. To describe and analyse the response of emergency physicians receiving calls for chest pain in the French Emergency Medical System. From 16 November to 13 December 2009, calls to the Medical Dispatch Centre for non-traumatic chest pain were included prospectively in a multicentre observational study. Clinical characteristics and triage decisions were collected. A total of 1647 patients were included in the study. An interview was conducted with the patient in only 30.5% of cases, and with relatives, bystanders or physicians in the other cases. A Mobile Intensive Care Unit was dispatched to 854 patients (51.9%) presenting with typical angina chest pains and a high risk of cardiovascular disease. Paramedics were sent to 516 patients (31.3%) and a general practitioner was sent to 169 patients (10.3%). Patients were given medical advice only by telephone in 108 cases (6.6%). Emergency physicians in the Medical Dispatch Centre sent an effecter to the majority of patients who called the Emergency Medical System for chest pain. The response level was based on the characteristics of the chest pain and the patient's risk profile. Copyright © 2014 Elsevier Masson SAS. All rights reserved.
    No preview · Article · Feb 2015 · Archives of Cardiovascular Diseases

  • No preview · Article · Jan 2015 · Archives of Cardiovascular Diseases

  • No preview · Article · Jan 2015 · Archives of Cardiovascular Diseases